https://sputnikglobe.com/20230110/australia-faces-shortage-of-antibiotics-due-to-disrupted-foreign-supplies--1106188976.html
Australia Faces Shortage of Antibiotics Due to Disrupted Foreign Supplies
Australia Faces Shortage of Antibiotics Due to Disrupted Foreign Supplies
Sputnik International
Australian pharmacies are experiencing shortage of antibiotics due to logistic issues with supplies from abroad
2023-01-10T08:38+0000
2023-01-10T08:38+0000
2023-01-10T08:41+0000
world
australia
antibiotics
medicine
healthcare
covid-19
painkillers
https://cdn1.img.sputnikglobe.com/img/106325/25/1063252545_0:67:1280:787_1920x0_80_0_0_c3c2408bd264c996c24472f58fb0b857.jpg
She added that the issue was caused by inadequate logistics and not by an increased demand. Adele Tahan noted that Australia did not produce many medications and relied on foreign supplies, which covered up to 90% of the country’s needs. Apart from disrupted supply chains, the expert said that dropping antibiotics prices in Australia made the country’s market less attractive for foreign manufacturers. The Americain media earlier reported, citing the WHO, that some US and European pharmacists registered shortage of popular pain killers, for example, paracetamol, due to growing demand caused by a great number of seasonal infections. Besides, they reported shortage of antibiotics, including penicillin and amoxicillin, across the globe. Healthcare experts say that during COVID-19 pandemic, the lower demand for antibiotics and economic recession forced manufacturers to decrease production of medicines. Now, in the first winter without restrictions in two years, companies are unable to ramp up output due to challenged supply chains, higher energy prices and various regulations.
australia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
shortage of antibiotics in australia, logistic issues, shortage of pain killers in us, shortage of pain killers in europe, covid-19 pandemic
shortage of antibiotics in australia, logistic issues, shortage of pain killers in us, shortage of pain killers in europe, covid-19 pandemic
Australia Faces Shortage of Antibiotics Due to Disrupted Foreign Supplies
08:38 GMT 10.01.2023 (Updated: 08:41 GMT 10.01.2023) MOSCOW (Sputnik) - Australian pharmacies are experiencing shortage of antibiotics due to logistic issues with supplies from abroad, Pharmacy Guild NSW Vice President Adele Tahan said on Tuesday.
"There are quite a significant number of antibiotics that are in short supply and they will remain so for quite some time," she said to Australian TV Channel.
She added that the issue was caused by inadequate logistics and not by an increased demand.
Adele Tahan noted that
Australia did not produce many medications and relied on foreign supplies, which covered up to 90% of the country’s needs.
"We have to rely on worldwide supply and unfortunately the situation right now is that we're waiting for the antibiotics to become available," Tahan told the broadcaster.
Apart from disrupted supply chains, the expert said that dropping
antibiotics prices in Australia made the country’s market less attractive for foreign manufacturers.
"Australia's not an attractive place for medicines to come to us. The American market is a massive market and the prices charged in America are much higher than what we can charge in Australia. It makes us the last country for medicine to come here," she added.
The Americain media earlier reported, citing the WHO, that some US and European pharmacists registered shortage of popular
pain killers, for example, paracetamol, due to growing demand caused by a great number of seasonal infections. Besides, they reported shortage of antibiotics, including penicillin and amoxicillin, across the globe.
Healthcare experts say that during
COVID-19 pandemic, the lower demand for antibiotics and economic recession forced manufacturers to decrease production of medicines. Now, in the first winter without restrictions in two years, companies are unable to ramp up output due to challenged supply chains, higher energy prices and various regulations.
